I have enough information now to write a comprehensive earnings preview. Let me pull together the key data points.# Jacobs Solutions Inc. (NYSE: J) — Q3 FY2026 Earnings Preview

Report date: Tuesday, August 4, 2026, after market close; conference call at 4:30 PM ET Fiscal period: Third quarter of fiscal 2026 (quarter ended on/around June 26, 2026) Stock context: Shares closed at $138.75 on August 3, 2026, near 52-week highs, after a volatile spring — the stock fell from ~$136 to ~$107 in mid-May (largely a reaction to the GAAP net loss tied to PA Consulting deal accounting) before rallying more than 25% into the print.

---

1. What Wall Street Is Looking For

Analyst consensus heading into the print calls for: - Adjusted EPS of ~$1.84, up roughly 13.6% year-over-year from $1.62, with the Zacks estimate having held steady over the past 30 days. - Gross revenue of ~$3.54 billion, up about 16.9% from $3.03 billion a year ago. - Segment operating profit of roughly $262 million for Infrastructure & Advanced Facilities (I&AF) (+11% y/y) and $83 million for PA Consulting (+15.3% y/y).

Jacobs has beaten consensus EPS in each of the last four quarters (average surprise ~4%), including a Q2 beat where adjusted EPS topped estimates by 6.7% and gross revenue beat by 13.8%. The bar is therefore set high, and the stock's recent run-up suggests investors are positioned for another beat-and-raise.

2. Company's Own Guidance for Q3

Management's own framework, laid out on the Q2 call, is the most important benchmark: - Adjusted EBITDA margin of ~15%, which would represent a roughly 90-basis-point sequential improvement from Q2's 14.1%. - Net revenue growth of ~7.5% y/y — a deceleration from the 9% organic net revenue growth delivered in Q2, which investors will want to understand (conservatism vs. a genuine moderation). - An adjusted effective tax rate of 27%–28% for both Q3 and Q4. - Guidance implicitly sets up for a >16% EBITDA margin in Q4, aided by an extra week in the fiscal fourth quarter and double-digit top-line growth.

Any signs that margin progression is tracking ahead of or behind this glide path will be a key swing factor for the stock reaction.

3. The PA Consulting Overhang — Watch the GAAP/Adjusted Spread

Q2 featured a GAAP net loss of $43.0 million (EPS of -$0.32) against adjusted EPS of $1.75, driven by one-time charges from closing the acquisition of the remaining stake in PA Consulting on March 20, 2026 — including roughly $235 million of accelerated equity-based compensation vesting and other transaction costs. Management explicitly flagged that this wide GAAP-to-adjusted spread was "mostly a Q2 phenomenon" and should normalize in Q3 and beyond, though CFO Venk Nathamuni also noted a further ~$105 million cash outflow (employee benefit trust payments) would hit Q3's reported (not adjusted) free cash flow. Investors should confirm: - GAAP EPS moves back toward adjusted EPS this quarter. - The now-100%-owned PA Consulting continues its run of double-digit revenue growth (it grew revenue 17% y/y in Q2, its fourth straight quarter of double-digit growth) and maintains its ~22% operating margin, with management guiding to high-single-digit constant-currency growth in H2. - Progress on the raised cost-synergy target of at least $20 million within 24 months (up from the original $16–20 million estimate at deal announcement) and early evidence of cross-sell/revenue synergies now that ownership barriers around joint pipeline visibility have been removed.

4. Growth Drivers to Track

• AI/data center infrastructure: This has become the marquee growth narrative. Data center revenue grew more than 100% y/y in Q2, and management said the broader "AI ecosystem" (chips through power/energy to data centers) represents 10%–11% of total company revenue and is growing over 40%. The data center pipeline alone was said to be up 400% y/y with visibility extending into FY27–FY28. Any deceleration or acceleration here will move the stock materially.
• Life sciences & advanced manufacturing: Net revenue grew 12% in Q2 — the highest growth rate since the company began reporting by end market — helped by semiconductor reshoring and a life sciences real-time pipeline that was up 81% y/y. Management expected H2 growth to exceed Q2's pace.
• Critical infrastructure: Up 9% in Q2, led by double-digit growth in transportation (aviation, rail, ports/maritime) and strength in energy & power tied to transmission/distribution demand. Recent contract wins include a DFW Terminal S design role and an eight-year UK transmission/distribution framework with Murphy for SSE.
• Water & Environmental: The laggard end market, up just 2% in Q2 as water strength was offset by environmental softness; management guided to a "meaningful year-over-year improvement" in environmental by Q4 — worth confirming this quarter.
• Backlog/bookings: Backlog hit a record $27.0 billion in Q2 (+21.7% y/y), with a trailing-12-month book-to-bill of 1.4x gross / 1.2x on net revenue. Sustained book-to-bill above 1.0x is the clearest forward indicator of the growth outlook into FY27.

5. Balance Sheet, Capital Returns and Cash Flow

• Net leverage stood at 2.1x at the end of Q2 (roughly half a turn above target) following debt raised for the PA transaction; management targets below 2x by fiscal year-end and ~1.5x in FY27, aided by a seasonally strong H2 (guided to $600–700 million of free cash flow in the second half).
• The company repurchased $220 million of stock in Q2 ($472 million year-to-date), running ahead of its commitment to return at least 60% of free cash flow to shareholders, and raised its quarterly dividend by 12.5% earlier in the year.
• Watch for commentary on whether buyback pace continues at this clip given the simultaneous deleveraging priority.

6. FY26 Guidance and Longer-Term Targets

Jacobs has already raised full-year FY26 guidance twice this year. Current targets are: adjusted net revenue growth of 8.0%–10.5%, adjusted EBITDA margin of 14.6%–14.9%, adjusted EPS of $7.10–$7.35 (implying ~18% EPS growth at the midpoint), and adjusted free cash flow margin of 7.0%–8.5%. A third raise, or at minimum a reaffirmation with confidence in the top end of the range, would be well received; any guidance trim would be a notable disappointment given how far shares have run.

Separately, at the Q2 call management also refreshed longer-term FY29 targets: reaffirmed 6%–8% organic net-revenue CAGR (with confidence toward the higher end given AI infrastructure exposure and PA revenue synergies), raised the adjusted EBITDA margin target by 100 bps to 17%+, and raised the free cash flow margin target by 100 bps to 11%+, implying $1.2–$1.3 billion of annual free cash flow by FY29.

7. Sentiment, Valuation and Risks

• Analyst sentiment is broadly constructive: consensus rating is "Buy" (roughly 30% Strong Buy, 30% Buy, 40% Hold among ~10 covering analysts as of mid-July), with average price targets clustered in the $150–$158 range (some as high as $180–$181), versus an ~$139 stock — suggesting the Street sees upside even after the recent rally. Recent actions have skewed positive: RBC reiterated a Buy, and Citi reportedly opened a bullish 90-day catalyst watch on the name in late July, while Baird has remained on the sidelines with a Neutral rating and a $126 target set back in April (since overtaken by the stock's rise).
• Key risks/watch items: (1) any slowdown in AI/data-center capex commitments among hyperscalers/Neoclouds that Jacobs is central to; (2) political/legislative uncertainty around IIJA reauthorization and federal infrastructure funding, though management has characterized even a continuing-resolution scenario as manageable given the long-tail nature of programs and being only ~50% outlaid on current IIJA funding; (3) Middle East geopolitical disruption to project delivery (minimal impact reported so far, mitigated by Jacobs' global delivery model); (4) execution risk on PA Consulting integration and realizing revenue/cost synergies; (5) valuation risk — with the stock up sharply into the print, even a solid quarter that merely meets expectations could trigger a "sell the news" reaction if margin or growth trends show any deceleration beyond what's already guided.

Bottom Line

Jacobs enters this print with strong momentum: record backlog, accelerating AI-infrastructure-linked growth, expanding margins, and two consecutive guidance raises this fiscal year. The setup for Q3 is straightforward — the company itself has guided to ~15% adjusted EBITDA margin and ~7.5% net revenue growth, and consensus EPS sits near $1.84. The most important things for investors to watch are: (1) whether margin expansion is tracking toward the implied >16% Q4 exit rate, (2) continued strength/acceleration in AI-driven data center, semiconductor and life sciences bookings, (3) normalization of the GAAP-to-adjusted EPS gap now that the PA Consulting transaction has closed, and (4) whether management raises FY26 guidance for a third straight quarter. Given the stock's strong run into the report, execution needs to match or exceed an already-elevated bar.